GenixPharmaceucticals Corporation (GENX) — Cash Flow Reinvestment Rate

Latest as of April 2020: 9.91x

GenixPharmaceucticals Corporation (GENX) has a Cash Flow Reinvestment Rate of 9.91x as of April 2020, reinvesting CA$1.26 Million (capex CA$0.00 plus investments CA$-1.26 Million) from operating cash flow of CA$126.87K. Check GenixPharmaceucticals Corporation cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

9.91x
(Capex + Investments) / Operating CF

Total Reinvested

CA$1.26 Million
Capex + Investments

Operating Cash Flow

CA$126.87K
CAD

Capital Expenditures

CA$0.00
CAD

GenixPharmaceucticals Corporation Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for GenixPharmaceucticals Corporation across 1 annual periods. Explore GenixPharmaceucticals Corporation (GENX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for GenixPharmaceucticals Corporation (2018–2018)

Year-by-year capital reinvestment analysis for GenixPharmaceucticals Corporation. For live market cap and broader valuation context, see GenixPharmaceucticals Corporation stock valuation.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2018 1.91x CA$65.34K CA$34.18K CA$0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow